Home Health and Hospice

At Home Healthcare, a provider of home healthcare services throughout Texas, has been acquired by Family Home Health Services, a portfolio company of The Edgewater Funds.

Investors Lean Towards Hospice Amid Disruption in Home Health Space – Jake Vesely and Kevin Palamara share some insight with Hospice News

Q4-2019 Home Health & Hospice Update – With uncertainty looming around the upcoming Patient-Driven Groupings Model (PDGM), strategic acquirers and investors have focused their attention towards the hospice space in the fourth quarter of 2019 resulting in robust transaction volume. Due to increased competition and a shrinking number of platform opportunities available, Provident has seen valuations drastically increase in the hospice space and expects multiples to remain high throughout 2020.

Q3-2019 Home Health & Hospice Update– Multiples are at all time highs for the home health and hospice industry, driven by the value proposition that in-home care provides to the overall health care system. Evident by Addus HomeCare’s acquisition of Hospice Partners of America, providers are willing to pay premium valuations to expand services offerings in a growing attempt to capture the entire continuum of care.

Market Trends and M&A in Home Health / Hospice– The home health and hospice market remains one of the most fragmented sectors within healthcare services with many independent players holding significant market share in their respective geographies. Given the wide breadth of smaller companies, demand for home-based care, and the non capital-intensive nature of the business, there is significant opportunity in the space for both private equity and strategic-led consolidation.

Q2-2019 Home Health & Hospice Update– The transition to value-based reimbursement, implementation of PDGM, and recent changes to Medicare Advantage have spurred M&A activity amongst other strategic initiatives in a growing attempt to capture the entire continuum of care.

Cannabis, Hemp Producers Targeted in May Health-Care Deals – The health-care industry is getting into the weed business.

Health-Care Deals Steady, Strong Through First Third of 2019– Consistency is the name of the game for health-care industry transactions in 2019 so far.

INSIGHT: Health Care M&A Transactions on Pace to Set Record in 2019– March madness is over for college basketball fans, but it’s just the beginning of a fast-paced year for health-care M&A activity.

Q1-2019 Home Health & Hospice Update– Provident expects continued M&A opportunities will arise from smaller agencies not having the operational capacity or resources to adjust to the new PDGM payment framework. Furthermore, larger providers such as Addus, Elara Caring, Humana, and LHC Group will continue to utilize their infrastructure to drive further consolidation in the industry.

Long-Term Care Deals Dominate Health Industry in February– The long-term care sector continued its domination of health-care deals in February, Bloomberg Law’s transactions advisory board says.

Private Equity Interest in Hospice Acquisition Expected to Rise in 2019 – As more private equity firms enter the post-acute health care arena, hospice organizations are increasingly pursuing mergers and acquisitions as a growth strategy, according to the recently released 4th quarter 2018 Home Health & Hospice Update from Provident Healthcare Partners.

Healthcare Services M&A: A 2018 Recap and Expectations for 2019 – Episode 8 of Provident’s Healthcare Dealcast

  • “Provident’s depth of experience and practical business savvy was demonstrated in their ability to cut through what sometimes looked like impasse.”

  • “Provident listened to our story, confirmed that our business was valuable and made us feel like this was the only transaction important to them.”

  • “After working with Provident on several transactions, it is evident that their extensive industry knowledge and deal expertise prove to be invaluable to their clients.”

  • “We would not have been successful navigating the process without Provident’s hard work and active participation. They exceeded our expectations and we would highly recommend them to any health care company seeking a knowledgeable and engaged investment banking firm.”

  • ”I have a tremendous amount of appreciation and gratitude to the Provident team for their hard work and diligence throughout this process. Each and every member of the Provident team is excellent at their jobs and it has been a pleasure working with such a professional team. Provident has provided outstanding guidance and counsel, and this deal could never have gotten done without Provident’s leadership.”

  • “A lot of investment bankers were interviewed, Provident was chosen. Provident delivered. My clients could not be happier.”

  • “While the decision to sell our business was a difficult one, Provident vigilantly represented and protected our best interests throughout the transaction.  Provident was the right choice for Cascade and I would recommend their services to anyone.”